SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000921895-20-002819
Filing Date
2020-11-06
Accepted
2020-11-06 16:14:44
Documents
6
Period of Report
2020-11-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k12566007_11052020.htm 8-K 22761
2 ex101to8k12566007_11052020.htm EX-10.1 108810
3 ex102to8k12566007_11052020.htm EX-10.2 108364
4 ex103to8k12566007_11052020.htm EX-10.3 70248
5 ex104to8k12566007_11052020.htm EX-10.4 105683
6 ex991to8k12566007_11052020.htm EX-99.1 9587
  Complete submission text file 0000921895-20-002819.txt   426859
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 201294569
SIC: 2834 Pharmaceutical Preparations